Hepatitis C virus (HCV)
Patients with HCV infection can be managed within the Hepatology services at the Royal Infirmary of Edinburgh, or the Regional Infectious Diseases Unit at the Western General Hospital. Some treatment clinics are run jointly with Substance Misuse Directorate, Primary Care health centres, and pharmacies.
Treatment of HCV is well tolerated and highly effective; almost 100% of infections are cured by tablets taken once daily for 8-12 weeks. All patients with evidence of active HCV infection should be referred for consideration of antiviral treatment. Where appropriate, patients with cirrhosis will be offered enrolment into HCC surveillance, consisting of 6 monthly liver ultrasound and serum AFP measurement, arranged through the Centre for Liver and Digestive Disorders (CLDD).
Testing:
Hepatitis C antibody testing is performed as the initial screening test (4.9mL brown capped gel tube). If the patient is already known to be HCV antibody positive, please send HCV RNA quantitative PCR to confirm active infection (9mL (or 2 x 2.6mL) red cap EDTA tubes).
The lab will reflexively test HCV PCR on all new HCV antibody positive samples.
For patients with poor venous access or needle phobia, dried blood spot (DBS) testing is also available – contact community BBV team at RIDU on 0131 537 2820 or email communitybbvteam@nhslothian.scot.nhs.uk opens a new window.
HCV antibody does not confer immunity to subsequent infection; HCV antibody positive and PCR negative patients should be counselled regarding risk factors for re-infection and offered regular screening with HCV PCR if there is ongoing exposure.
Please see the BBV page opens a new window for additional information on testing, referrals, primary care management and resources.
C.M & E.S/N.B 06-02-24